Kenya: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Kenya

The Kenyan prophylactic medicaments containing insulin market was estimated at $X in 2022, increasing by 8.6% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption enjoyed a strong increase. Over the period under review, the market attained the peak level at $X in 2020; however, from 2021 to 2022, consumption remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Kenya

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses were finally on the rise to reach X kg for the first time since 2019, thus ending a two-year declining trend. In general, exports, however, saw a slight contraction. The pace of growth was the most pronounced in 2016 with an increase of 2,526% against the previous year. Over the period under review, the exports attained the maximum at X tons in 2019; however, from 2020 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 when exports increased by 2,929%. The exports peaked at $X in 2020; however, from 2021 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Uganda (X kg) was the main destination for prophylactic medicaments containing insulin exports from Kenya, accounting for a 39% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Uganda exceeded the volume sent to the second major destination, Tanzania (X kg), twofold. The third position in this ranking was held by Somalia (X kg), with a 16% share.

From 2012 to 2022, the average annual growth rate of volume to Uganda totaled +21.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Tanzania (+14.6% per year) and Somalia (+21.8% per year).

In value terms, Uganda ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Kenya, comprising 56% of total exports. The second position in the ranking was taken by Somalia ($X), with a 23% share of total exports. It was followed by Rwanda, with a 14% share.

From 2012 to 2022, the average annual growth rate of value to Uganda stood at +17.0%. Exports to the other major destinations recorded the following average annual rates of exports growth: Somalia (+13.7% per year) and Rwanda (-7.8% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, shrinking by -13.5% against the previous year. Overall, the export price, however, showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2014 when the average export price increased by 109%. As a result, the export price attained the peak level of $X per ton. From 2015 to 2022, the average export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Malawi ($X per ton), while the average price for exports to Tanzania ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Rwanda (+13.3%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Kenya

Prophylactic medicaments containing insulin imports into Kenya surged to X tons in 2022, growing by 16% against 2021 figures. In general, imports saw a prominent increase. The most prominent rate of growth was recorded in 2014 when imports increased by 116% against the previous year. Over the period under review, imports attained the maximum at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports rose remarkably to $X in 2022. Overall, imports recorded strong growth. The most prominent rate of growth was recorded in 2014 with an increase of 124%. Imports peaked at $X in 2020; however, from 2021 to 2022, imports failed to regain momentum.

Imports by Country

India (X tons), France (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Kenya, with a combined 45% share of total imports. Germany, the United States, Switzerland, Belgium and Bangladesh lagged somewhat behind, together comprising a further 32%.

From 2012 to 2022, the biggest increases were recorded for Belgium (with a CAGR of +33.1%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X), France ($X) and Germany ($X) constituted the largest prophylactic medicaments containing insulin suppliers to Kenya, together comprising 49% of total imports. India, the United States, Switzerland, Belgium and Bangladesh lagged somewhat behind, together accounting for a further 17%.

Belgium, with a CAGR of +36.3%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, with a decrease of -6.6% against the previous year. In general, import price indicated mild growth from 2012 to 2022: its price increased at an average annual rate of +1.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price decreased by -13.5% against 2019 indices. The pace of growth was the most pronounced in 2017 an increase of 38%. The import price peaked at $X per ton in 2019; however, from 2020 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Bangladesh ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+11.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :